Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Percutaneous balloon mitral valvuloplasty results throughout the decades: more complications and less success – are we dealing with more severe cases?
Session:
Posters (Sessão 6 - Écran 2) - Intervenção não coronária
Speaker:
Sofia Jacinto
Congress:
CPC 2023
Topic:
H. Interventional Cardiology and Cardiovascular Surgery
Theme:
25. Interventional Cardiology
Subtheme:
25.3 Non-coronary Cardiac Intervention
Session Type:
Pósters Electrónicos
FP Number:
---
Authors:
Sofia Jacinto; Ana Raquel Santos; Luís Almeida Morais; Luís Bernardes; Duarte Cacela; Inês Rodrigues; Ana Galrinho; Luísa Moura Branco; Ana Teresa Timóteo; Pedro Rio; Cristina Soares; Cristina Fondinho; Rui Cruz Ferreira
Abstract
<p style="text-align:justify"><span style="font-size:medium"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><strong>Background: </strong>Percutaneous balloon mitral valvuloplasty (PBMV) revolutionized the treatment of mitral valve stenosis and set the stage for the development of structural heart intervention in general. However, with the decline in rheumatic heart disease in developed countries, PBMV seems to be performed less frequently.</span></span></span></p> <p style="text-align:justify"><span style="font-size:medium"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><strong>Aim</strong>: To assess the evolution of PBMV outcomes throughout the decades.</span></span></span></p> <p style="text-align:justify"><span style="font-size:medium"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><strong>Methods</strong>: A retrospective analysis of PBMV performed at a tertiary center. Procedures were divided in 3 tertiles according to date (T1 – 1991 to 2001; T2 – 2002 to 2011; and T3 – 2012 to 2022). Adverse outcomes at 1 year included all-cause death or need for mitral reintervention.</span></span></span></p> <p style="text-align:justify"><span style="font-size:medium"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><strong>Results: </strong>There was a decrease in the number of PBMV performed in the different tertiles, with n=143 in T1, n=60 in T2 and n=35 in T3. Clinical data was similar with 89% female patients in T1, 85% in T2 and 94% in T3. Mean patient age was 50±15 years in T1, 45±15 years in T2, and 49±16 years in T3. </span></span></span><span style="font-size:medium"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><span style="color:black">Regarding pre-procedural echocardiographic evaluation, the proportion of </span>patients with a Wilkins’ score >8 was higher in T2 and T3, compared with T1 (15.9% in T1 vs. 28.9% in T2 and T3; p=0.032). Procedural success was achieved in a lower proportion of patients in the last decade (89.1% in T1, 89.3% in T2 and 80.6% in T3, p=0.281). Acute, non-fatal, complications showed a decreasing tendency in proportion between T1 and T2 (10.9% vs. 5.4%), but a slight increase between T2 and T3 (5.4% vs. 15.6%). Adverse outcomes at one year were less frequent between T1 and T2 (7.7% vs. 5%) but higher between T2 and T3 (5% vs. 14.3%), mostly due to reintervention. There was, however, a steady decrease in the number of deaths. Causes of death in T1 were unknown (n=2) and pulmonary embolism (n=1); in T2 there was 1 death of a non-cardiovascular cause (pneumonia).</span></span></span></p> <p style="text-align:justify"> </p> <p style="text-align:justify"><span style="font-size:medium"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><strong>Conclusion</strong>: In <span style="color:black">this study we find a steady decline in PBMV frequency throughout the years. There seems to be, during the 2000s, an improvement in the success of the procedure as well as fewer complications and adverse outcomes after 1 year. This could represent a “golden age” in PBMV, whereas the operators gathered enough experience and still regularly performed the procedure. However, in the last decade, the fewer number of procedures and less favorable mitral anatomy, may explain the higher proportion of acute complications. Despite this tendency, the relatively low frequency of adverse events and high procedural success still supports PBMV as a safe intervention for mitral stenosis.</span></span></span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site